Skip to main content

Institutional filer profile

OrbiMed Israel GP II L.P. Insider Trades

Latest reported as Corporate insider of ADARx Pharmaceuticals, Inc. (ADRX).

Purchase filings
1
Reported companies
1
Net open-market value
$16,150,000
Latest transaction
Sep 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 28, 2026ADARx Pharmaceuticals, Inc. (ADRX)Corporate insiderOpen Market Purchase950,000$17.00$16,150,000